Stock Analysis of Nexalin Technology Inc. (NXL) - Birds Eye View

1W   2W   1M   3M   1Y   2Y   5Y   
Overview
Code NXL
Close 1.54
Change 0.0350 / 2.33 %
Volume 9814.00
Vol Change -1888.00 / 16.13 %
IndustryMedical Devices
SectorHealthcare
AIO Strength Index
Technical StrengthBearish
Growth Index Very Low Growth Stock
Value Index Poor Value Stock
Profitability Index Poor Profitability Stock
Stability Index Excellent Stability


Fundamental View of Nexalin Technology Inc.
PE (TTM)

-0.110

Very Poor
Price / Book

0.263

Excellent
Price / Sales

4.57

Very Poor
Piotroski F Score

3.0

Not Good
Market Cap

1614.73 K

Enterprise Value

959948

ROA (TTM)

-195.21

Very Poor
ROE (TTM)

-237.98

Very Poor
Net Margin (TTM)

-4139.38

Very Poor
Revenue

78.78 %

301647
Net Profit

8.08 %

-8222.18 K
Debt to Equity

0

Excellent
Altman Z Score

-32.00

Very Poor
Quick Ratio

4.70

Very Good
Cash Ratio

4.20

Very Good


Highs/Lows of Nexalin Technology Inc.
PeriodOld priceStock ReturnS&P 500 ReturnsHighLowHigh DateLow Date
One Week1.646.10 % 1.99 % 1.731.4128-Oct-2602-Nov-26
Two Week2.1428.04 % 1.86 % 2.181.4121-Oct-2602-Nov-26
One Month5.7373.12 % 1.99 % 6.301.4105-Oct-2602-Nov-26
Three Month10.9585.93 % 0.416 % 12.411.4104-Aug-2602-Nov-26
Six Months11.4186.50 % 4.69 % 19.201.4101-Jun-2602-Nov-26
One year44.1096.51 % 10.46 % 43.501.4105-Nov-2502-Nov-26
Two year94.8098.38 % 32.12 % 134.701.4104-Dec-2402-Nov-26


Technical View of Nexalin Technology Inc.
RSI

26.26

Mild Bullish
MACD

-0.912

Mild Bullish
ADX

17.86

Neutral
Super Trend

2.54

Mild Bearish
Williams %R

-88.98

Bullish
CCI

-85.20

Neutral


EMA 5

1.60

Mild Bearish
EMA 15

2.11

Mild Bearish
EMA 50

4.42

Strong Bearish
EMA 100

7.11

Strong Bearish
SMA 100

7.87

Strong Bearish
SMA 200

10.71

Strong Bearish
SMA 5 / 20

1.58 / 2.35

Mild Bearish
SMA 15 / 50

1.93 / 4.28

Strong Bearish
SMA 50 / 200

4.28 / 10.71

Strong Bearish




Charts of Nexalin Technology Inc.


Returns of Nexalin Technology Inc. with Peers
Period / StockNXLIVFCUTRTIVCVAXX
1 Week-6.10%-21.28%-16.10%-60.71%-18.92%
1 Mth-73.12%-43.27%-76.53%-60.71%14900.00%
3 Mth-85.93%-50.26%-72.93%-40.85%14900.00%
6mth-86.50%-74.47%-85.79%-62.84%-
1 Year-96.51%-97.73%-95.20%-85.55%14900.00%
2 Year-98.38%-99.96%-99.67%-91.70%650.00%
5 Years--100.00%-99.41%--
charts-
View All Together in Chart      Inline           Tile

Compare Fundamentals of Nexalin Technology Inc. with Peers
Ratio / StockNXLIVFVAXX
PE-0.1100.195-0.0381
P/B0.2630.0560.072
ROA-195.2110.84-82.33
ROE-237.9828.72-189.51
Debt To Equity00.3081.13
Revenue301647
78.78 % 		6841.25 K
4.73 % 		0
100.00 %
Net Income-8222.18 K
8.08 % 		-23323.05 K
156.41 % 		-65998.00 K
12.26 %


Technicals of Nexalin Technology Inc. with Peers
Technical / StockNXLIVFCUTRTIVCVAXX-
ADX17.8635.9528.4338.4814.86
CMF-0.486-0.491-0.6630.691-0.953
MFI12.6220.2673.8188.7896.54
RSI26.2629.5524.4334.6751.72
MACD Abv SignalTrueTrueFalseFalseTrue
Price Above 50 MAFalseFalseFalseFalseTrue-
Price Above 200 MAFalseFalseFalseFalseTrue-


About : Nexalin Technology Inc.

Address : 1776 Yorktown, Houston, TX, United States, 77056
Tel : 832 260 0222
URL : https://www.nexalin.com
Code : NXL, ISIN : US65345B2016, Exchange : NASDAQ, Country : USA
Fiscal Year End : December
IPO date : 16_Sep_2022
Employee Count : 8

Nexalin Technology, Inc., a medical device company, designs and develops neurostimulation products for the treatment of mental health epidemic in the United States and China. The company offers Generation 1, an easy-to-administer medical device which utilizes bioelectronic medical technology to treat anxiety, insomnia, and depression without the need for drugs or psychotherapy; and Generation 2 and Generation 3 headset devices for the treatment of depression, substance use disorder, traumatic brain injury, post-traumatic stress disorder, opioid addiction, alcoholism, and chronic pain, as well as alzheimer's disease, and dementia. Nexalin Technology, Inc. is headquartered in Houston, Texas.


Note : All Data Generated at the End of Trading Hours (EOD Data)